TAKE Solutions Limited (NSE:TAKE)
India · Delayed Price · Currency is INR 47.39
+0.13 (0.28%)
Feb 19, 2026, 3:30 PM IST
TAKE Solutions Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
6.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | 36.02M | -1.85B | -98.09% |
| Mar 31, 2023 | 1.89B | -4.64B | -71.03% |
| Mar 31, 2022 | 6.53B | -1.21B | -15.68% |
| Mar 31, 2021 | 7.74B | -14.39B | -65.02% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biocon | 168.27B |
| Dishman Carbogen Amcis | 27.97B |
| Anthem Biosciences | 20.02B |
| OneSource Specialty Pharma | 14.19B |
| Concord Biotech | 11.59B |
| Blue Jet Healthcare | 10.53B |
| Supriya Lifescience | 7.35B |
| Panacea Biotec | 6.06B |